nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoteridol—Bradycardia—Prednisolone—multiple sclerosis	0.0031	0.0031	CcSEcCtD
Gadoteridol—Face oedema—Prednisone—multiple sclerosis	0.00309	0.00309	CcSEcCtD
Gadoteridol—Hypotension—Azathioprine—multiple sclerosis	0.00305	0.00305	CcSEcCtD
Gadoteridol—Cardiac arrest—Prednisone—multiple sclerosis	0.00305	0.00305	CcSEcCtD
Gadoteridol—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.003	0.003	CcSEcCtD
Gadoteridol—Sweating—Methylprednisolone—multiple sclerosis	0.00299	0.00299	CcSEcCtD
Gadoteridol—Hypersensitivity—Cladribine—multiple sclerosis	0.00296	0.00296	CcSEcCtD
Gadoteridol—Malaise—Mitoxantrone—multiple sclerosis	0.00292	0.00292	CcSEcCtD
Gadoteridol—Bradycardia—Triamcinolone—multiple sclerosis	0.00286	0.00286	CcSEcCtD
Gadoteridol—Bradycardia—Methylprednisolone—multiple sclerosis	0.00285	0.00285	CcSEcCtD
Gadoteridol—Pruritus—Cladribine—multiple sclerosis	0.00284	0.00284	CcSEcCtD
Gadoteridol—Cough—Mitoxantrone—multiple sclerosis	0.00282	0.00282	CcSEcCtD
Gadoteridol—Rhinitis—Triamcinolone—multiple sclerosis	0.00281	0.00281	CcSEcCtD
Gadoteridol—Rhinitis—Methylprednisolone—multiple sclerosis	0.00281	0.00281	CcSEcCtD
Gadoteridol—Convulsion—Mitoxantrone—multiple sclerosis	0.0028	0.0028	CcSEcCtD
Gadoteridol—Hypertension—Mitoxantrone—multiple sclerosis	0.00279	0.00279	CcSEcCtD
Gadoteridol—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.00277	0.00277	CcSEcCtD
Gadoteridol—Chest pain—Mitoxantrone—multiple sclerosis	0.00275	0.00275	CcSEcCtD
Gadoteridol—Diarrhoea—Cladribine—multiple sclerosis	0.00275	0.00275	CcSEcCtD
Gadoteridol—Anxiety—Mitoxantrone—multiple sclerosis	0.00275	0.00275	CcSEcCtD
Gadoteridol—Discomfort—Mitoxantrone—multiple sclerosis	0.00272	0.00272	CcSEcCtD
Gadoteridol—Feeling abnormal—Azathioprine—multiple sclerosis	0.00269	0.00269	CcSEcCtD
Gadoteridol—Dizziness—Cladribine—multiple sclerosis	0.00266	0.00266	CcSEcCtD
Gadoteridol—Erythema—Prednisolone—multiple sclerosis	0.00265	0.00265	CcSEcCtD
Gadoteridol—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00264	0.00264	CcSEcCtD
Gadoteridol—Oedema—Mitoxantrone—multiple sclerosis	0.00264	0.00264	CcSEcCtD
Gadoteridol—Shock—Mitoxantrone—multiple sclerosis	0.0026	0.0026	CcSEcCtD
Gadoteridol—Bradycardia—Dexamethasone—multiple sclerosis	0.00259	0.00259	CcSEcCtD
Gadoteridol—Bradycardia—Betamethasone—multiple sclerosis	0.00259	0.00259	CcSEcCtD
Gadoteridol—Body temperature increased—Azathioprine—multiple sclerosis	0.00258	0.00258	CcSEcCtD
Gadoteridol—Abdominal pain—Azathioprine—multiple sclerosis	0.00258	0.00258	CcSEcCtD
Gadoteridol—Vomiting—Cladribine—multiple sclerosis	0.00255	0.00255	CcSEcCtD
Gadoteridol—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00255	0.00255	CcSEcCtD
Gadoteridol—Rash—Cladribine—multiple sclerosis	0.00253	0.00253	CcSEcCtD
Gadoteridol—Dermatitis—Cladribine—multiple sclerosis	0.00253	0.00253	CcSEcCtD
Gadoteridol—Headache—Cladribine—multiple sclerosis	0.00252	0.00252	CcSEcCtD
Gadoteridol—Hypotension—Mitoxantrone—multiple sclerosis	0.00247	0.00247	CcSEcCtD
Gadoteridol—Ill-defined disorder—Prednisolone—multiple sclerosis	0.00246	0.00246	CcSEcCtD
Gadoteridol—Erythema—Triamcinolone—multiple sclerosis	0.00244	0.00244	CcSEcCtD
Gadoteridol—Erythema—Methylprednisolone—multiple sclerosis	0.00244	0.00244	CcSEcCtD
Gadoteridol—Hypersensitivity—Azathioprine—multiple sclerosis	0.00241	0.00241	CcSEcCtD
Gadoteridol—Malaise—Prednisolone—multiple sclerosis	0.00239	0.00239	CcSEcCtD
Gadoteridol—Dysgeusia—Triamcinolone—multiple sclerosis	0.00239	0.00239	CcSEcCtD
Gadoteridol—Nausea—Cladribine—multiple sclerosis	0.00239	0.00239	CcSEcCtD
Gadoteridol—Syncope—Prednisolone—multiple sclerosis	0.00238	0.00238	CcSEcCtD
Gadoteridol—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00237	0.00237	CcSEcCtD
Gadoteridol—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00235	0.00235	CcSEcCtD
Gadoteridol—Loss of consciousness—Prednisolone—multiple sclerosis	0.00233	0.00233	CcSEcCtD
Gadoteridol—Convulsion—Prednisolone—multiple sclerosis	0.0023	0.0023	CcSEcCtD
Gadoteridol—Hypertension—Prednisolone—multiple sclerosis	0.00229	0.00229	CcSEcCtD
Gadoteridol—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.00227	0.00227	CcSEcCtD
Gadoteridol—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.00226	0.00226	CcSEcCtD
Gadoteridol—Pain—Mitoxantrone—multiple sclerosis	0.00226	0.00226	CcSEcCtD
Gadoteridol—Bradycardia—Prednisone—multiple sclerosis	0.00226	0.00226	CcSEcCtD
Gadoteridol—Diarrhoea—Azathioprine—multiple sclerosis	0.00224	0.00224	CcSEcCtD
Gadoteridol—Discomfort—Prednisolone—multiple sclerosis	0.00223	0.00223	CcSEcCtD
Gadoteridol—Erythema—Dexamethasone—multiple sclerosis	0.00222	0.00222	CcSEcCtD
Gadoteridol—Erythema—Betamethasone—multiple sclerosis	0.00222	0.00222	CcSEcCtD
Gadoteridol—Malaise—Triamcinolone—multiple sclerosis	0.0022	0.0022	CcSEcCtD
Gadoteridol—Malaise—Methylprednisolone—multiple sclerosis	0.0022	0.0022	CcSEcCtD
Gadoteridol—Syncope—Triamcinolone—multiple sclerosis	0.00219	0.00219	CcSEcCtD
Gadoteridol—Syncope—Methylprednisolone—multiple sclerosis	0.00218	0.00218	CcSEcCtD
Gadoteridol—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00218	0.00218	CcSEcCtD
Gadoteridol—Oedema—Prednisolone—multiple sclerosis	0.00217	0.00217	CcSEcCtD
Gadoteridol—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00217	0.00217	CcSEcCtD
Gadoteridol—Dizziness—Azathioprine—multiple sclerosis	0.00216	0.00216	CcSEcCtD
Gadoteridol—Loss of consciousness—Triamcinolone—multiple sclerosis	0.00215	0.00215	CcSEcCtD
Gadoteridol—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.00214	0.00214	CcSEcCtD
Gadoteridol—Shock—Prednisolone—multiple sclerosis	0.00213	0.00213	CcSEcCtD
Gadoteridol—Cough—Triamcinolone—multiple sclerosis	0.00213	0.00213	CcSEcCtD
Gadoteridol—Convulsion—Triamcinolone—multiple sclerosis	0.00212	0.00212	CcSEcCtD
Gadoteridol—Convulsion—Methylprednisolone—multiple sclerosis	0.00211	0.00211	CcSEcCtD
Gadoteridol—Hypertension—Triamcinolone—multiple sclerosis	0.00211	0.00211	CcSEcCtD
Gadoteridol—Hypertension—Methylprednisolone—multiple sclerosis	0.0021	0.0021	CcSEcCtD
Gadoteridol—Urticaria—Mitoxantrone—multiple sclerosis	0.0021	0.0021	CcSEcCtD
Gadoteridol—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00209	0.00209	CcSEcCtD
Gadoteridol—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00209	0.00209	CcSEcCtD
Gadoteridol—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00209	0.00209	CcSEcCtD
Gadoteridol—Vomiting—Azathioprine—multiple sclerosis	0.00208	0.00208	CcSEcCtD
Gadoteridol—Anxiety—Methylprednisolone—multiple sclerosis	0.00207	0.00207	CcSEcCtD
Gadoteridol—Rash—Azathioprine—multiple sclerosis	0.00206	0.00206	CcSEcCtD
Gadoteridol—Dermatitis—Azathioprine—multiple sclerosis	0.00206	0.00206	CcSEcCtD
Gadoteridol—Flushing—Prednisone—multiple sclerosis	0.00206	0.00206	CcSEcCtD
Gadoteridol—Ill-defined disorder—Betamethasone—multiple sclerosis	0.00206	0.00206	CcSEcCtD
Gadoteridol—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.00206	0.00206	CcSEcCtD
Gadoteridol—Discomfort—Triamcinolone—multiple sclerosis	0.00205	0.00205	CcSEcCtD
Gadoteridol—Discomfort—Methylprednisolone—multiple sclerosis	0.00205	0.00205	CcSEcCtD
Gadoteridol—Headache—Azathioprine—multiple sclerosis	0.00205	0.00205	CcSEcCtD
Gadoteridol—Dry mouth—Triamcinolone—multiple sclerosis	0.00203	0.00203	CcSEcCtD
Gadoteridol—Malaise—Betamethasone—multiple sclerosis	0.002	0.002	CcSEcCtD
Gadoteridol—Malaise—Dexamethasone—multiple sclerosis	0.002	0.002	CcSEcCtD
Gadoteridol—Oedema—Triamcinolone—multiple sclerosis	0.00199	0.00199	CcSEcCtD
Gadoteridol—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00199	0.00199	CcSEcCtD
Gadoteridol—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00199	0.00199	CcSEcCtD
Gadoteridol—Syncope—Dexamethasone—multiple sclerosis	0.00199	0.00199	CcSEcCtD
Gadoteridol—Syncope—Betamethasone—multiple sclerosis	0.00199	0.00199	CcSEcCtD
Gadoteridol—Sweating—Methotrexate—multiple sclerosis	0.00198	0.00198	CcSEcCtD
Gadoteridol—Shock—Triamcinolone—multiple sclerosis	0.00196	0.00196	CcSEcCtD
Gadoteridol—Shock—Methylprednisolone—multiple sclerosis	0.00196	0.00196	CcSEcCtD
Gadoteridol—Loss of consciousness—Dexamethasone—multiple sclerosis	0.00195	0.00195	CcSEcCtD
Gadoteridol—Loss of consciousness—Betamethasone—multiple sclerosis	0.00195	0.00195	CcSEcCtD
Gadoteridol—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00195	0.00195	CcSEcCtD
Gadoteridol—Paraesthesia—Prednisolone—multiple sclerosis	0.00195	0.00195	CcSEcCtD
Gadoteridol—Nausea—Azathioprine—multiple sclerosis	0.00194	0.00194	CcSEcCtD
Gadoteridol—Erythema—Prednisone—multiple sclerosis	0.00193	0.00193	CcSEcCtD
Gadoteridol—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00193	0.00193	CcSEcCtD
Gadoteridol—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00192	0.00192	CcSEcCtD
Gadoteridol—Convulsion—Betamethasone—multiple sclerosis	0.00192	0.00192	CcSEcCtD
Gadoteridol—Convulsion—Dexamethasone—multiple sclerosis	0.00192	0.00192	CcSEcCtD
Gadoteridol—Hypertension—Betamethasone—multiple sclerosis	0.00191	0.00191	CcSEcCtD
Gadoteridol—Hypertension—Dexamethasone—multiple sclerosis	0.00191	0.00191	CcSEcCtD
Gadoteridol—Anxiety—Dexamethasone—multiple sclerosis	0.00188	0.00188	CcSEcCtD
Gadoteridol—Anxiety—Betamethasone—multiple sclerosis	0.00188	0.00188	CcSEcCtD
Gadoteridol—Discomfort—Dexamethasone—multiple sclerosis	0.00186	0.00186	CcSEcCtD
Gadoteridol—Discomfort—Betamethasone—multiple sclerosis	0.00186	0.00186	CcSEcCtD
Gadoteridol—Hypotension—Methylprednisolone—multiple sclerosis	0.00186	0.00186	CcSEcCtD
Gadoteridol—Pain—Prednisolone—multiple sclerosis	0.00185	0.00185	CcSEcCtD
Gadoteridol—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00181	0.00181	CcSEcCtD
Gadoteridol—Oedema—Betamethasone—multiple sclerosis	0.00181	0.00181	CcSEcCtD
Gadoteridol—Oedema—Dexamethasone—multiple sclerosis	0.00181	0.00181	CcSEcCtD
Gadoteridol—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00181	0.00181	CcSEcCtD
Gadoteridol—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00181	0.00181	CcSEcCtD
Gadoteridol—Ill-defined disorder—Prednisone—multiple sclerosis	0.00179	0.00179	CcSEcCtD
Gadoteridol—Paraesthesia—Triamcinolone—multiple sclerosis	0.00179	0.00179	CcSEcCtD
Gadoteridol—Feeling abnormal—Prednisolone—multiple sclerosis	0.00179	0.00179	CcSEcCtD
Gadoteridol—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00179	0.00179	CcSEcCtD
Gadoteridol—Shock—Dexamethasone—multiple sclerosis	0.00178	0.00178	CcSEcCtD
Gadoteridol—Shock—Betamethasone—multiple sclerosis	0.00178	0.00178	CcSEcCtD
Gadoteridol—Dyspnoea—Triamcinolone—multiple sclerosis	0.00178	0.00178	CcSEcCtD
Gadoteridol—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00175	0.00175	CcSEcCtD
Gadoteridol—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00175	0.00175	CcSEcCtD
Gadoteridol—Malaise—Prednisone—multiple sclerosis	0.00174	0.00174	CcSEcCtD
Gadoteridol—Syncope—Prednisone—multiple sclerosis	0.00173	0.00173	CcSEcCtD
Gadoteridol—Tinnitus—Methotrexate—multiple sclerosis	0.00173	0.00173	CcSEcCtD
Gadoteridol—Urticaria—Prednisolone—multiple sclerosis	0.00172	0.00172	CcSEcCtD
Gadoteridol—Pain—Triamcinolone—multiple sclerosis	0.0017	0.0017	CcSEcCtD
Gadoteridol—Loss of consciousness—Prednisone—multiple sclerosis	0.0017	0.0017	CcSEcCtD
Gadoteridol—Hypotension—Dexamethasone—multiple sclerosis	0.00169	0.00169	CcSEcCtD
Gadoteridol—Hypotension—Betamethasone—multiple sclerosis	0.00169	0.00169	CcSEcCtD
Gadoteridol—Vomiting—Mitoxantrone—multiple sclerosis	0.00168	0.00168	CcSEcCtD
Gadoteridol—Convulsion—Prednisone—multiple sclerosis	0.00167	0.00167	CcSEcCtD
Gadoteridol—Hypertension—Prednisone—multiple sclerosis	0.00167	0.00167	CcSEcCtD
Gadoteridol—Rash—Mitoxantrone—multiple sclerosis	0.00167	0.00167	CcSEcCtD
Gadoteridol—Dermatitis—Mitoxantrone—multiple sclerosis	0.00166	0.00166	CcSEcCtD
Gadoteridol—Headache—Mitoxantrone—multiple sclerosis	0.00165	0.00165	CcSEcCtD
Gadoteridol—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00164	0.00164	CcSEcCtD
Gadoteridol—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00164	0.00164	CcSEcCtD
Gadoteridol—Anxiety—Prednisone—multiple sclerosis	0.00164	0.00164	CcSEcCtD
Gadoteridol—Paraesthesia—Dexamethasone—multiple sclerosis	0.00162	0.00162	CcSEcCtD
Gadoteridol—Paraesthesia—Betamethasone—multiple sclerosis	0.00162	0.00162	CcSEcCtD
Gadoteridol—Discomfort—Prednisone—multiple sclerosis	0.00162	0.00162	CcSEcCtD
Gadoteridol—Erythema—Methotrexate—multiple sclerosis	0.00161	0.00161	CcSEcCtD
Gadoteridol—Hypersensitivity—Prednisolone—multiple sclerosis	0.0016	0.0016	CcSEcCtD
Gadoteridol—Urticaria—Triamcinolone—multiple sclerosis	0.00158	0.00158	CcSEcCtD
Gadoteridol—Urticaria—Methylprednisolone—multiple sclerosis	0.00158	0.00158	CcSEcCtD
Gadoteridol—Dysgeusia—Methotrexate—multiple sclerosis	0.00158	0.00158	CcSEcCtD
Gadoteridol—Body temperature increased—Triamcinolone—multiple sclerosis	0.00158	0.00158	CcSEcCtD
Gadoteridol—Oedema—Prednisone—multiple sclerosis	0.00157	0.00157	CcSEcCtD
Gadoteridol—Anaphylactic shock—Prednisone—multiple sclerosis	0.00157	0.00157	CcSEcCtD
Gadoteridol—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00157	0.00157	CcSEcCtD
Gadoteridol—Nausea—Mitoxantrone—multiple sclerosis	0.00157	0.00157	CcSEcCtD
Gadoteridol—Shock—Prednisone—multiple sclerosis	0.00155	0.00155	CcSEcCtD
Gadoteridol—Pain—Betamethasone—multiple sclerosis	0.00155	0.00155	CcSEcCtD
Gadoteridol—Pain—Dexamethasone—multiple sclerosis	0.00155	0.00155	CcSEcCtD
Gadoteridol—Hyperhidrosis—Prednisone—multiple sclerosis	0.00152	0.00152	CcSEcCtD
Gadoteridol—Ill-defined disorder—Methotrexate—multiple sclerosis	0.0015	0.0015	CcSEcCtD
Gadoteridol—Feeling abnormal—Betamethasone—multiple sclerosis	0.00149	0.00149	CcSEcCtD
Gadoteridol—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00149	0.00149	CcSEcCtD
Gadoteridol—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00147	0.00147	CcSEcCtD
Gadoteridol—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00146	0.00146	CcSEcCtD
Gadoteridol—Malaise—Methotrexate—multiple sclerosis	0.00145	0.00145	CcSEcCtD
Gadoteridol—Urticaria—Dexamethasone—multiple sclerosis	0.00144	0.00144	CcSEcCtD
Gadoteridol—Urticaria—Betamethasone—multiple sclerosis	0.00144	0.00144	CcSEcCtD
Gadoteridol—Dizziness—Prednisolone—multiple sclerosis	0.00143	0.00143	CcSEcCtD
Gadoteridol—Body temperature increased—Dexamethasone—multiple sclerosis	0.00143	0.00143	CcSEcCtD
Gadoteridol—Abdominal pain—Dexamethasone—multiple sclerosis	0.00143	0.00143	CcSEcCtD
Gadoteridol—Body temperature increased—Betamethasone—multiple sclerosis	0.00143	0.00143	CcSEcCtD
Gadoteridol—Abdominal pain—Betamethasone—multiple sclerosis	0.00143	0.00143	CcSEcCtD
Gadoteridol—Paraesthesia—Prednisone—multiple sclerosis	0.00141	0.00141	CcSEcCtD
Gadoteridol—Pruritus—Triamcinolone—multiple sclerosis	0.00141	0.00141	CcSEcCtD
Gadoteridol—Cough—Methotrexate—multiple sclerosis	0.00141	0.00141	CcSEcCtD
Gadoteridol—Pruritus—Methylprednisolone—multiple sclerosis	0.00141	0.00141	CcSEcCtD
Gadoteridol—Convulsion—Methotrexate—multiple sclerosis	0.0014	0.0014	CcSEcCtD
Gadoteridol—Chest pain—Methotrexate—multiple sclerosis	0.00137	0.00137	CcSEcCtD
Gadoteridol—Rash—Prednisolone—multiple sclerosis	0.00137	0.00137	CcSEcCtD
Gadoteridol—Dermatitis—Prednisolone—multiple sclerosis	0.00136	0.00136	CcSEcCtD
Gadoteridol—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00136	0.00136	CcSEcCtD
Gadoteridol—Headache—Prednisolone—multiple sclerosis	0.00136	0.00136	CcSEcCtD
Gadoteridol—Discomfort—Methotrexate—multiple sclerosis	0.00136	0.00136	CcSEcCtD
Gadoteridol—Dizziness—Triamcinolone—multiple sclerosis	0.00132	0.00132	CcSEcCtD
Gadoteridol—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00132	0.00132	CcSEcCtD
Gadoteridol—Dizziness—Methylprednisolone—multiple sclerosis	0.00131	0.00131	CcSEcCtD
Gadoteridol—Feeling abnormal—Prednisone—multiple sclerosis	0.0013	0.0013	CcSEcCtD
Gadoteridol—Nausea—Prednisolone—multiple sclerosis	0.00129	0.00129	CcSEcCtD
Gadoteridol—Pruritus—Betamethasone—multiple sclerosis	0.00128	0.00128	CcSEcCtD
Gadoteridol—Pruritus—Dexamethasone—multiple sclerosis	0.00128	0.00128	CcSEcCtD
Gadoteridol—Hyperhidrosis—Methotrexate—multiple sclerosis	0.00127	0.00127	CcSEcCtD
Gadoteridol—Vomiting—Triamcinolone—multiple sclerosis	0.00127	0.00127	CcSEcCtD
Gadoteridol—Vomiting—Methylprednisolone—multiple sclerosis	0.00126	0.00126	CcSEcCtD
Gadoteridol—Rash—Triamcinolone—multiple sclerosis	0.00126	0.00126	CcSEcCtD
Gadoteridol—Dermatitis—Triamcinolone—multiple sclerosis	0.00126	0.00126	CcSEcCtD
Gadoteridol—Rash—Methylprednisolone—multiple sclerosis	0.00125	0.00125	CcSEcCtD
Gadoteridol—Dermatitis—Methylprednisolone—multiple sclerosis	0.00125	0.00125	CcSEcCtD
Gadoteridol—Urticaria—Prednisone—multiple sclerosis	0.00125	0.00125	CcSEcCtD
Gadoteridol—Headache—Triamcinolone—multiple sclerosis	0.00125	0.00125	CcSEcCtD
Gadoteridol—Headache—Methylprednisolone—multiple sclerosis	0.00125	0.00125	CcSEcCtD
Gadoteridol—Abdominal pain—Prednisone—multiple sclerosis	0.00124	0.00124	CcSEcCtD
Gadoteridol—Body temperature increased—Prednisone—multiple sclerosis	0.00124	0.00124	CcSEcCtD
Gadoteridol—Diarrhoea—Dexamethasone—multiple sclerosis	0.00124	0.00124	CcSEcCtD
Gadoteridol—Diarrhoea—Betamethasone—multiple sclerosis	0.00124	0.00124	CcSEcCtD
Gadoteridol—Hypotension—Methotrexate—multiple sclerosis	0.00123	0.00123	CcSEcCtD
Gadoteridol—Dizziness—Dexamethasone—multiple sclerosis	0.0012	0.0012	CcSEcCtD
Gadoteridol—Dizziness—Betamethasone—multiple sclerosis	0.0012	0.0012	CcSEcCtD
Gadoteridol—Nausea—Triamcinolone—multiple sclerosis	0.00118	0.00118	CcSEcCtD
Gadoteridol—Paraesthesia—Methotrexate—multiple sclerosis	0.00118	0.00118	CcSEcCtD
Gadoteridol—Nausea—Methylprednisolone—multiple sclerosis	0.00118	0.00118	CcSEcCtD
Gadoteridol—Dyspnoea—Methotrexate—multiple sclerosis	0.00117	0.00117	CcSEcCtD
Gadoteridol—Hypersensitivity—Prednisone—multiple sclerosis	0.00116	0.00116	CcSEcCtD
Gadoteridol—Vomiting—Dexamethasone—multiple sclerosis	0.00115	0.00115	CcSEcCtD
Gadoteridol—Vomiting—Betamethasone—multiple sclerosis	0.00115	0.00115	CcSEcCtD
Gadoteridol—Rash—Dexamethasone—multiple sclerosis	0.00114	0.00114	CcSEcCtD
Gadoteridol—Rash—Betamethasone—multiple sclerosis	0.00114	0.00114	CcSEcCtD
Gadoteridol—Dermatitis—Dexamethasone—multiple sclerosis	0.00114	0.00114	CcSEcCtD
Gadoteridol—Dermatitis—Betamethasone—multiple sclerosis	0.00114	0.00114	CcSEcCtD
Gadoteridol—Headache—Dexamethasone—multiple sclerosis	0.00113	0.00113	CcSEcCtD
Gadoteridol—Headache—Betamethasone—multiple sclerosis	0.00113	0.00113	CcSEcCtD
Gadoteridol—Pain—Methotrexate—multiple sclerosis	0.00113	0.00113	CcSEcCtD
Gadoteridol—Pruritus—Prednisone—multiple sclerosis	0.00111	0.00111	CcSEcCtD
Gadoteridol—Feeling abnormal—Methotrexate—multiple sclerosis	0.00108	0.00108	CcSEcCtD
Gadoteridol—Diarrhoea—Prednisone—multiple sclerosis	0.00108	0.00108	CcSEcCtD
Gadoteridol—Nausea—Dexamethasone—multiple sclerosis	0.00107	0.00107	CcSEcCtD
Gadoteridol—Nausea—Betamethasone—multiple sclerosis	0.00107	0.00107	CcSEcCtD
Gadoteridol—Urticaria—Methotrexate—multiple sclerosis	0.00105	0.00105	CcSEcCtD
Gadoteridol—Dizziness—Prednisone—multiple sclerosis	0.00104	0.00104	CcSEcCtD
Gadoteridol—Abdominal pain—Methotrexate—multiple sclerosis	0.00104	0.00104	CcSEcCtD
Gadoteridol—Body temperature increased—Methotrexate—multiple sclerosis	0.00104	0.00104	CcSEcCtD
Gadoteridol—Vomiting—Prednisone—multiple sclerosis	0.001	0.001	CcSEcCtD
Gadoteridol—Rash—Prednisone—multiple sclerosis	0.000993	0.000993	CcSEcCtD
Gadoteridol—Dermatitis—Prednisone—multiple sclerosis	0.000992	0.000992	CcSEcCtD
Gadoteridol—Headache—Prednisone—multiple sclerosis	0.000986	0.000986	CcSEcCtD
Gadoteridol—Hypersensitivity—Methotrexate—multiple sclerosis	0.000969	0.000969	CcSEcCtD
Gadoteridol—Nausea—Prednisone—multiple sclerosis	0.000935	0.000935	CcSEcCtD
Gadoteridol—Pruritus—Methotrexate—multiple sclerosis	0.000931	0.000931	CcSEcCtD
Gadoteridol—Diarrhoea—Methotrexate—multiple sclerosis	0.0009	0.0009	CcSEcCtD
Gadoteridol—Dizziness—Methotrexate—multiple sclerosis	0.00087	0.00087	CcSEcCtD
Gadoteridol—Vomiting—Methotrexate—multiple sclerosis	0.000837	0.000837	CcSEcCtD
Gadoteridol—Rash—Methotrexate—multiple sclerosis	0.00083	0.00083	CcSEcCtD
Gadoteridol—Dermatitis—Methotrexate—multiple sclerosis	0.000829	0.000829	CcSEcCtD
Gadoteridol—Headache—Methotrexate—multiple sclerosis	0.000824	0.000824	CcSEcCtD
Gadoteridol—Nausea—Methotrexate—multiple sclerosis	0.000782	0.000782	CcSEcCtD
